Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient

Journal of Virology

Volumn 79, Issue 24, 2005, Pages 15323-15330

  Zeng, Mu Sheng ^a   Li, Da Jiang ^a   Liu, Qing Lun ^a   Song, Li Bing ^a   Li, Man Zhi ^a   Zhang, Ru Hua ^a   Yu, Xing Juan ^a   Wang, Hui Min ^a   Ernberg, Ingemar ^b   Zeng, Yi Xin ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE; VIRUS DNA;

ARTICLE; CHINA; EPSTEIN BARR VIRUS; GENE SEQUENCE; GENOME; INCIDENCE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; SEQUENCE ANALYSIS;

HUMAN HERPESVIRUS 4;

EID: 29744445111     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.24.15323-15330.2005     Document Type: Article

References (60)

1. Abdel-Hamid, M., J. J. Chen, N. Constantine, M. Massoud, and N. Raab-Traub. 1992. EBV strain variation: geographical distribution and relation to disease state. Virology 190:168-175.
2. Adldinger, H. K., H. Delius, U. K. Freese, J. Clarke, and G. W. Bornkamm. 1985. A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141:221-234.
3. Arrand, J. R., L. S. Young, and J. D. Tugwood. 1989. Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J. Virol. 63:983-986.
4. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, et al. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
5. Bhatia, K., A. Raj, M. I. Guitierrez, J. G. Judde, G. Spangler, H. Venkatesh, and I. T. Magrath. 1996. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13:177-181.
6. Bornkamm, G. W., H. Delius, U. Zimber, J. Hudewentz, and M. A. Epstein. 1980. Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. J. Virol. 35:603-618.
7. Busson, P., C. Keryer, T. Ooka, and M. Corbex. 2004. EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. Trends Microbiol. 12:356-360.
8. Chang, Y. S., I. J. Su, P. J. Chung, C. H. Shu, C. K. Ng, S. J. Wu, and S. T. Liu. 1995. Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int. J. Cancer 62:673-677.
9. Chen, M. L., C. N. Tsai, C. L. Liang, C. H. Shu, C. R. Huang, D. Sulitzeanu, S. T. Liu, and Y. S. Chang. 1992. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131-2140.
10. Cheung, S. T., S. F. Leung, K. W. Lo, K. W. Chiu, J. S. Tam, T. F. Fok, P. J. Johnson, J. C. Lee, and D. P. Huang. 1998. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int. J. Cancer 76:399-406.
11. Cheung, S. T., K. W. Lo, S. F. Leung, W. Y. Chan, P. H. Choi, P. J. Johnson, J. C. Lee, and D. P. Huang. 1996. Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int. J. Cancer 66:711-712.
12. Crawford, D. H., M. A. Epstein, G. W. Bornkamm, B. G. Achong, S. Finerty, and J. L. Thompson. 1979. Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas. Int. J. Cancer 24:294-302.
13. Desgranges, C., M. F. Lavoue, J. Patet, and G. de-The. 1979. In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains. Biomedicine 30:102-108.
14. de Turenne-Tessier, M., P. Jolicoeur, J. M. Middeldorp, and T. Ooka. 2005. Expression and analysis of the Epstein-Barr virus BARF1-encoded protein from a tetracydine-regulatable adenovirus system. Virus Res. 109:9-18.
15. Edwards, R. H., F. Seillier-Moiseiwitsch, and N. Raab-Traub. 1999. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 261:79-95.
16. Edwards, R. H., D. Sitki-Green, D. T. Moore, and N. Raab-Traub. 2004. Potential selection of LMP1 variants in nasopharyngeal carcinoma. J. Virol. 78:868-881.
17. Epstein, M. A., B. G. Achong, Y. M. Barr, B. Zajac, G. Henle, and W. Henle. 1966. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J. Natl. Cancer Inst. 37:547-559.
18. Feng, B. J., W. Huang, Y. Y. Shugart, M. K. Lee, F. Zhang, J. C. Xia, H. Y. Wang, T. B. Huang, S. W. Jian, P. Huang, Q. S. Feng, L. X. Huang, X. J. Yu, D. Li, L. Z. Chen, W. H. Jia, Y. Fang, H. M. Huang, J. L. Zhu, X. M. Liu, Y. Zhao, W. Q. Liu, M. Q. Deng, W. H. Hu, S. X. Wu, H. Y. Mo, M. F. Hong, M. C. King, Z. Chen, and Y. X. Zeng. 2002. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat. Genet. 31:395-399.
19. Gutierrez, M. I., A. Raj, G. Spangler, A. Sharma, A. Hussain, J. G. Judde, S. W. Tsao, P. W. Yuen, I. Joab, I. T. Magrath, and K. Bhatia. 1997. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J. Gen. Virol. 78:1663-1670.
20. Hamilton-Dutoit, S. J., G. Pallesen, M. B. Franzmann, J. Karkov, F. Black, P. Skinhoj, and C. Pedersen. 1991. AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am. J. Pathol. 138:149-163.
21. Hinuma, Y., M. Konn, J. Yamaguchi, D. J. Wudarski, J. R. Blakeslee, Jr., and J. T. Grace, Jr. 1967. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J. Virol. 1:1045-1051.
22. Hu, L. F., E. R. Zabarovsky, F. Chen, S. L. Cao, I. Ernberg, G. Klein, and G. Winberg. 1991. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J. Gen. Virol. 72:2399-2409.
23. Imai, S., S. Koizumi, M. Sugiura, M. Tokunaga, Y. Uemura, N. Yamamoto, S. Tanaka, E. Sato, and T. Osato. 1994. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc. Natl. Acad. Sci. USA 91:9131-9135.
24. Janse van Rensburg, E., W. F. van Heerden, B. A. Robson, T. J. Swart, and S. Engelbrecht. 2000. Epstein-Barr virus strain characterisation in South African patients with nasopharyngeal carcinomas. Anticancer Res. 20:1953-1957.
25. Jeng, K. C., C. Y. Hsu, M. T. Liu, T. T. Chung, and S. T. Liu. 1994. Prevalence of Taiwan variant of Epstein-Barr virus in throat washings from patients with head and neck tumors in Taiwan. J. Clin. Microbiol. 32:28-31.
26. Khanim, F., Q. Y. Yao, G. Niedobitek, S. Sihota, A. B. Rickinson, and L. S. Young. 1996. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88:3491-3501.
27. Klein, G., B. C. Giovanella, T. Lindahl, P. J. Fialkow, S. Singh, and J. S. Stehlin. 1974. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc. Natl. Acad. Sci. USA 71:4737-4741.
28. Knecht, H., E. Bachmann, P. Brousset, S. Rothenberger, H. Einsele, V. S. Lestou, G. Delsol, F. Bachmann, P. F. Ambros, and B. F. Odermatt. 1995. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 10:523-528.
29. Knecht, H., F. Martius, E. Bachmann, T. Hoffman, D. R. Zimmermann, S. Rothenberger, K. Sandvej, W. Wegmann, N. Hurwitz, B. F. Odermatt, et al. 1995. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Leukemia 9:458-465.
30. Leung, S. Y., S. T. Yuen, L. P. Chung, A. S. Chan, and M. P. Wong. 1997. Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese. Int. J. Cancer 72:225-230.
31. Li, S. N., Y. S. Chang, and S. T. Liu. 1996. Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 12:2129-2135.
32. Lin, J. C., B. K. De, and S. C. Lin. 1993. Rapid and sensitive genotyping of Epstein-Barr virus using single-strand conformation polymorphism analysis of polymerase chain reaction products. J. Virol. Methods 43:233-246.
33. Lung, M. L., W. P. Lam, J. Sham, D. Choy, Z. Yong-Sheng, H. Y. Guo, and M. H. Ng. 1991. Detection and prevalence of the "f" variant of Epstein-Barr virus in southern China. Virology 185:67-71.
34. Mai, S. J., X. S. Zhang, D. J. Li, G. P. Shen, J. H. Jiang, R. H. Zhang, X. J. Yu, S. P. Chen, and Y. X. Zeng. 2004. The character of EBNA1 gene variation in Cantonese and its association with nasopharyngeal carcinoma. Chin. Sci. Bull. 49:1-4.
35. Miller, G., D. Coope, J. Niederman, and J. Pagano. 1976. Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis-derived strains of Epstein-Barr virus released from transformed marmoset cells. J. Virol. 18:1071-1080.
36. Miller, G., T. Shope, H. Lisco, D. Stitt, and M. Lipman. 1972. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc. Natl. Acad. Sci. USA 69:383-387.
37. Pallesen, G., S. J. Hamilton-Dutoit, and X. Zhou. 1993. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field. Adv. Cancer Res. 62:179-239.
38. Parker, B. D., A. Bankier, S. Satchwell, B. Barrell, and P. J. Farrell. 1990. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 179:339-346.
39. Pulvertaft, J. V. 1965. A study of malignant tumours in Nigeria by short-term tissue culture. J. Clin. Pathol. 18:261-273.
40. Raab-Traub, N., R. Pritchett, and E. Kieff. 1978. DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus. J. Virol. 27:388-398.
41. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa.
42. Rickinson, A. B., L. S. Young, and M. Rowe. 1987. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J. Virol. 61:1310-1317.
43. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1992. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
44. Sample, J., L. Young, B. Martin, T. Chatman, E. Kieff, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64:4084-4092.
45. Sandvej, K., X. G. Zhou, and S. Hamilton-Dutoit. 2000. EBNA-1 sequence variation in Danish and Chinese EBV-associated tumours: evidence for geographical polymorphism but not for tumour-specific subtype restriction. J. Pathol. 191:127-131.
46. Seto, E., L. Yang, J. Middeldorp, T. S. Sheen, J. Y. Chen, M. Fukayama, Y. Eizuru, T. Ooka, and K. Takada. 2005. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J. Med. Virol. 76:82-88.
47. Sheng, W., A. Bouguermouh, M. Bouzid, D. Djennaoui, and T. Ooka. 2004. BAMHIDNA fragment H-polymorphism of Epstein-Barr virus is associated with the mutations present in an 89 BP sequence localized in EBNA2 gene. Virus Genes 29:99-108.
48. Skare, J., C. Edson, J. Farley, and J. L. Strominger. 1982. The B95-8 isolate of Epstein-Barr virus arose from an isolate with a standard genome. J. Virol. 44:1088-1091.
49. Snudden, D. K., P. R. Smith, D. Lai, M. H. Ng, and B. E. Griffin. 1995. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene 10:1545-1552.
50. Song, L. B., Y. X. Zeng, Y. H. Ma, Q. L. Liu, M. Z. Li, D. Li, and H. M. Wang. 2001. Sequence analysis of EBV-BARF0 gene in nasopharyngeal carcinoma from Guangdong area. Chin. J. Cancer 20:464-467. (In Chinese.)
51. Sung, N. S., R. H. Edwards, F. Seillier-Moiseiwitsch, A. G. Perkins, Y. Zeng, and N. Raab-Traub. 1998. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int. J. Cancer 76:207-215.
52. Takada, K., and Y. Ono. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:445-449.
53. Wang, W. Y., Y. C. Chien, J. S. Jan, C. M. Chueh, and J. C. Lin. 2002. Consistent sequence variation of Epstein-Barr virus nuclear antigen 1 in primary tumor and peripheral blood cells of patients with nasopharyngeal carcinoma. Clin. Cancer Res. 8:2586-2590.
54. Weiss, L. M., L. A. Movahed, R. A. Warnke, and J. Sklar. 1989. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 320:502-506.
55. Young, L. S., Q. Y. Yao, C. M. Rooney, T. B. Sculley, D. J. Moss, H. Rupani, G. Laux, G. W. Bornkamm, and A. B. Rickinson. 1987. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J. Gen. Virol. 68:2853-2862.
56. Zhang, X. S., K. H. Song, H. Q. Mai, W. H. Jia, B. J. Feng, J. C. Xia, R. H. Zhang, L. X. Huang, X. J. Yu, Q. S. Feng, P. Huang, J. J. Chen, and Y. X. Zeng. 2002. The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China. Cancer Lett. 176:65-73.
57. Zhang, X. S., H. H. Wang, L. F. Hu, A. Li, R. H. Zhang, H. Q. Mai, J. C. Xia, L. Z. Chen, and Y. X. Zeng. 2004. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Lett. 211:11-18.
58. Zhang, X. S., L. J. Zhang, R. H. Zhang, H. Q. Mai, J. J. Chen, and Y. X. Zeng. 2001. Relationship between polymorphism of Epstein-Barr virus-encoded small RNAs and nasopharyngeal carcinomas. J. Practical Oncol. 16:301-303.
59. Zimber, U., H. K. Adldinger, G. M. Lenoir, M. Vuillaume, M. V. Knebel-Doeberitz, G. Laux, C. Desgranges, P. Wittmann, U. K. Freese, U. Schneider, et al. 1986. Geographical prevalence of two types of Epstein-Barr virus. Virology 154:56-66.
60. zur Hausen, H., H. Schulte-Holthausen, G. Klein, W. Henle, G. Henle, P. Clifford, and L. Santesson. 1970. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228:1056-1058.